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S Su um mm ma ar ry y
Glypicans are heparan sulfate proteoglycans that are bound to the outer surface of the plasma
membrane by a glycosyl-phosphatidylinositol anchor. Homologs of glypicans are found throughout
the Eumetazoa. There are six family members in mammals (GPC1 to GPC6). Glypicans can be
released from the cell surface by a lipase called Notum, and most of them are subjected to
endoproteolytic cleavage by furin-like convertases. In vivo evidence published so far indicates
that the main function of membrane-attached glypicans is to regulate the signaling of Wnts,
Hedgehogs, fibroblast growth factors and bone morphogenetic proteins (BMPs). Depending on
the context, glypicans may have a stimulatory or inhibitory activity on signaling. In the case of
Wnt, it has been proposed that the stimulatory mechanism is based on the ability of glypicans to
facilitate and/or stabilize the interaction of Wnts with their signaling receptors, the Frizzled
proteins. On the other hand, GPC3 has recently been reported to inhibit Hedgehog protein
signaling during development by competing with Patched, the Hedgehog receptor, for Hedgehog
binding. Surprisingly, the regulatory activity of glypicans in the Wnt, Hedgehog and BMP signaling
pathways is only partially dependent on the heparan sulfate chains.
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G Ge en ne e   o or rg ga an ni iz za at ti io on n   a an nd d   e ev vo ol lu ut ti io on na ar ry y   h hi is st to or ry y
Glypicans are heparan sulfate proteoglycans that are bound
to the external surface of the plasma membrane by a
glycosyl-phosphatidylinositol (GPI) linkage [1,2]. Homologs
of glypican are found throughout the Eumetazoa, with at
least two genes in the starlet anemone Nematostella
vectensis. Clear glypican homologs are not found outside the
Metazoa. There are six glypican family members in the
human genome (GPC1 to GPC6). The mouse genome also
has six glypicans, which are identified by the same nomen-
clature (Table 1). Glypicans fall into two broad subfamilies:
glypicans 1/2/4/6 and glypicans 3/5 (Figure 1), with approxi-
mately 25% amino-acid identity between groups. Within the
first subfamily, glypicans 4 and 6 are relatively closely
related (64% identity) and glypicans 1 and 2 form a more
divergent clade. A single representative of each of the two
subfamilies is present in Drosophila: Dally, an ortholog of
the mammalian glypican 3/5 subfamily, and Dally-like
protein, an ortholog of the glypican 1/2/4/6 subfamily. Basal
deuterostomes such as the sea urchin also have one repre-
sentative of each subfamily. Expansions of the multigene
family in the lineage leading to mammals are thus charac-
terized by an ancient gene duplication preceding the appear-
ance of the common bilaterian (and possibly eumetazoan)
ancestor giving rise to the two major subfamilies, followed
by one or two rounds of duplication that probably took place
in a vertebrate ancestor.
A notable genomic feature in the mouse and human genome
is the presence of closely linked genes that form two glypican
clusters: glypicans 3/4 on the X chromosome, and glypicans
5/6 on human chromosome 13 (mouse chromosome 14).
Both of these clusters comprise one member of each of the
two major glypican subfamilies, suggesting that their linkagehttp://genomebiology.com/2008/9/5/224 Genome B Bi io ol lo og gy y 2008, Volume 9, Issue 5, Article 224 Filmus et al. 224.2
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T Ta ab bl le e   1 1
G Gl ly yp pi ic ca an ns s   i in n   h hu um ma an ns s   a an nd d   D Dr ro os so op ph hi il la a
Gene accession  Number of 
Gene name Synonyms Location number (GenBank) amino acids Reference
Human
GPC1 Glypican 2q35-37 NM_002081 558 [40]
GPC2 Cerebroglycan 7q22.1 NM_152742 579 [41]
GPC3 OCI-5, MXR7 Xq26 NM_004484 580 [42]
GPC4 K-glypican Xq26.1 NM_001448 556 [9]
GPC5 13q32 NM_004466.3 572 [43]
GPC6 13q32 NM_005708.2 555 [44]
Drosophila
Dally 3L,66E1-66E3 NM_079259.2 626 [45]
Dally-like protein (Dlp) 3L,70E5-70E7 NM_206353.1 939 [46]
F Fi ig gu ur re e   1 1
Interrelationships among glypican proteins. The phylogeny was inferred using the neighbor-joining method. The tree is a bootstrap consensus generated
from 1,000 replicates using the MEGA4 program suite [47]. The percentage of replicates in which the associated sequences cluster is shown next to
branches. All positions containing gaps were eliminated from the dataset. The bar at the bottom indicates proportion of amino-acid differences. The
species used are human (Hs), mouse (Mm), zebrafish (Dr), purple sea urchin (Sp), and fruit fly (Dm). Dlp, Dally-like protein. NCBI accession numbers for
the sequences used in the analysis are as follows: HsGPC1, NP_002072.2; HsGPC2, NP_689955.1; HsGPC3, NP_004475.1; HsGPC4, NP_001439.2;
HsGPC5, NP_004457.1; HsGPC6, NP_005699.1; MmGPC1, NP_057905.1; MmGPC2, NP_766000.1; MmGPC3, NP_057906.2; MmGPC4, NP_032176;
MmGPC5, NP_780709.1; MmGPC6, NP_001073313.1; DrKNY, NP_571935; DmDally, AAA97401.1; DmDlp, AAG38110.1. Sea urchin sequences
obtained from models generated in the Sea Urchin Genome Project [48] are as follows: SpGPC1/2/4/6, GLEAN3_03084; SpGPC3/5, GLEAN3_13086. A
scan of the zebrafish genome reveals additional GPC family members, but complete transcript sequences are not available. The full complement of GPC
genes is shown for the other species.
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0.05may be ancient. Five glypican-like genes are present in the
zebrafish genome (Ensembl [3]). Four of these zebrafish
genes are linked in two clusters: a GPC3/Kny cluster and a
GPC5/GPC1 cluster. Drosophila Dally and Dally-like protein
are encoded on the same chromosome, but are far more
distantly linked than are the mammalian clusters.
Glypican proteins are between 555 and 580 amino acids in
length, and are encoded in eight to ten exons in human. The
size of these genes can extend from a very compact 7.7 kb for
human GPC2 to an expansive 1.5 Mb for human GPC5. This
remarkable divergence in gene size begs the question of
whether the small glypicans (GPC1 and 2) differ in some
essential way from the much larger relatives in terms of
complexity of gene usage or other regulatory characteristics.
C Ch ha ar ra ac ct te er ri is st ti ic c   s st tr ru uc ct tu ur ra al l   f fe ea at tu ur re es s
Because there are no reports on the analysis of glypicans by
X-ray crystallography or other imaging techniques, our
knowledge of the three-dimensional structure of glypicans is
very limited. Furthermore, glypicans do not seem to have
domains with significant homology to characterized struc-
tures. It is clear, however, that the three-dimensional struc-
ture of glypicans is highly conserved across the family, as the
localization of 14 cysteine residues is preserved in all family
members [4]. A weak identity between a fragment that
extends approximately from residue 200 to residue 300 of
glypicans and the cysteine-rich domain of Frizzled proteins
has been reported [5]. Whether this has functional implica-
tions is still unknown, however. Another interesting struc-
tural feature shared by all glypicans is the insertion sites for
the heparan sulfate (HS) chains, which are located close to
the carboxyl terminus. This places the HS chains close to the
cell surface, suggesting that these chains could mediate the
interaction of glypicans with other cell-surface molecules,
including growth factor receptors.
Most glypicans, including those of Drosophila [6], are sub-
jected to endoproteolytic cleavage by a furin-like convertase
[7]. This cleavage has been observed in vivo [8], and in
many types of cultured cells [7,9]. The cleavage site is
located at the carboxy-terminal end of the CRD domain,
and generates two subunits that remain attached to each
other by one or more disulfide bonds [7]. Whether the
convertase-induced cleavage of glypicans is complete, and
whether it occurs in all cell types, is still unknown. It should
be noted, however, that this cleavage is not required for all
glypican functions [10].
GPC5 displays a mixture of HS and chondroitin sulfate when
transiently transfected into Cos-7 cells [11]. It remains to be
seen whether the unexpected presence of chondroitin sulfate
chains in a glypican is just a peculiarity of transiently
transfected Cos-7 cells, or whether endogenous GPC5 can
also display such chains at least in specific tissues.
L Lo oc ca al li iz za at ti io on n   a an nd d   f fu un nc ct ti io on n
As expected for proteins that carry GPI anchors, glypicans
are mostly found at the cell membrane. In polarized cells,
GPI-anchored proteins are usually located at the apical
membrane. It is thought that apical sorting is due to their
association with lipid rafts [12]. These are cell-membrane
subdomains that are glycolipid-enriched and detergent-
resistant. It has been proposed that these domains facilitate
selective protein-protein interactions that establish transient
cell-signaling platforms [13]. Unlike other GPI-anchored
proteins, however, significant amounts of glypicans can be
found outside lipid rafts, and at the basolateral membranes
of polarized cells [14]. Interestingly, the HS chains seem to
play a critical role in this unexpected localization, since non-
glycanated glypicans are sorted apically [14]. Most of the in
vivo evidence published so far indicates that the main
function of membrane-attached glypicans is to regulate the
signaling of Wnts, Hedgehogs (Hhs), fibroblast growth
factors (FGFs), and bone morphogenetic proteins (BMPs)
[5,15-18]. For example, GPC3-null mice display alterations
in Wnt and Hh signaling [16,19], and Drosophila glypican
mutants have defective Hh, Wnt, BMP and FGF signaling in
specific tissues [15,18,20,21]. Furthermore, GPC3 promotes
the growth of hepatocellular carcinoma cells by stimulating
Wnt signaling [22]. The function of glypicans is not limited
to the regulation of growth factor activity. For example,
Dally-like protein, a Drosophila glypican, has been shown to
play a role in synapse morphogenesis and function by bind-
ing and inhibiting the receptor phosphatase LAR [23]. In
addition, it has been proposed that glypicans can be involved
in the uptake of polyamines [24].
Glypicans can also be shed into the extracellular environ-
ment. This shedding is generated, at least in part, by Notum,
an extracellular lipase that releases glypicans by cleaving the
GPI anchor [25,26]. Studies in Drosophila have demon-
strated that shed glypicans play a role in the transport of
Wnts, Hhs and BMPs for the purpose of morphogen gradient
formation [27-32]. Interestingly, glypicans have been found
in lipophorins, the Drosophila lipoproteins. These particles
are critical for the long-range activity of Wnts and Hhs
[6,33]. In the particular case of Hh, it has been proposed
that the glypicans in lipophorins may promote the formation
of ligand-receptor complexes in the target cells [6].
In addition to their localization on the cell membrane and in
the extracellular environment, glypicans can also be found in
the cytoplasm. In particular, there have been several studies
reporting the presence of GPC3 in the cytoplasm of liver
cancer cells [34,35]. Whether cytoplasmic GPC3 plays a
specific role is unknown.
M Me ec ch ha an ni is sm m   o of f   a ac ct ti io on n
Depending on the biological context, glypicans can either
stimulate or inhibit signaling activity. In the case of the
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stimulatory mechanism is based on the ability of glypicans to
facilitate and/or stabilize the interaction of Wnts with their
signaling receptors, the Frizzled proteins (Figure 2) [22].
This hypothesis is based on the finding that glypicans can
bind to Wnts and to Frizzleds [16,18,22,36], and that
transfection of glypicans increases the Wnt-binding capacity
of the transfected cells [22]. In the case of Hhs, it has been
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F Fi ig gu ur re e   2 2
Positive and negative effects of GPC3 on cell signaling. In the Wnt signaling pathway (left), GPC3 exerts a positive effect. Wnt binds to the receptor
Frizzled to induce signaling (green arrow). GPC3 facilitates and/or stabilizes the interaction between Wnt and Frizzled with the consequent increment on
signaling. In the Hedgehog (Hh) signaling pathway (right), GPC3 exerts an inhibitory effect. The binding of Hh to the receptor Patched (Ptc) triggers the
signaling pathway by blocking the inhibitory activity of Ptc on Smoothened. GPC3 competes with Ptc for Hh binding. The interaction of Hh with GPC3































Smoothenedrecently reported that GPC3 inhibits their signaling during
development by competing with Patched, the Hh receptor,
for Hh binding (Figure 2) [19]. The binding of Hh to GPC3
triggers its endocytosis and degradation. On the other hand,
it has been shown that the Drosophila glypican Dally-like
protein stimulates Hh signaling, although the mechanism of
this stimulatory activity remains unknown [37].
Because the HS chains have a strong negative charge, HS
proteoglycans can interact in a rather promiscuous way with
proteins that display positively charged domains. On this
basis it was originally thought that the HS chains were
essential for glypican activity. Indeed, this seems to be the
case for the glypican-induced stimulation of FGF activity
[38]. However, recent experimental evidence has demon-
strated that the HS chains are only partially required for the
regulatory activity of glypicans in Hh, Wnt and BMP
signaling [16,19,39]. Furthermore, Hh has been shown to
bind to the core protein of GPC3 with high affinity [19].
F Fr ro on nt ti ie er rs s
One of the main issues that requires attention in the near
future is the cellular and molecular basis of the context
specificity that characterizes glypican activity. For example,
what is the reason for the opposite effects of GPC3 and
Dally-like protein on Hh signaling? Equally important will
be a detailed characterization of the interaction of glypicans
with Hhs, Wnts, and BMPs. Some of the questions to be
answered in this regard are: Do all glypican core proteins
interact with Hhs, Wnts and BMPs? What are the domains
involved in these interactions? Do glypicans interact with
the corresponding signaling receptors?
A further important topic of investigation will be the role
of glypicans in morphogen gradient formation. We still do
not understand the precise role of these proteins in
regulating morphogen movement. Furthermore, whether
glypicans are involved in this process in mammals
remains to be investigated.
It is obvious that our knowledge of glypican functions is still
very limited despite the recent advances. A better under-
standing of these functions will make a significant
contribution to the study of signaling pathways that play a
very important role in developmental morphogenesis and
several human diseases, including cancer.
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